Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

The discussion covered plans to increase the agency's headcount and to expedite early through late-stage clinical development in the U.S.

Discoveries may help to explain why some bacteria are hard to eliminate, and also point to potential future approaches to improving antibiotic effectiveness.

Researchers say newly identified cholesterol control pathway is completely separate from anything targeted by existing drugs.

The physical AI platform, named AI Experimentalist, translates research goals from natural language into experiments at scale.

Researchers advance scalable stem-cell bioprocessing with AI-enabled manufacturing for regenerative medicine therapies.

This GEN Spotlight on RNA Therapeutics brings you three interlinked sessions that feature outstanding researchers exploring various aspects of RNA biology and therapeutics.

Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...

Analysis of lung fluid samples indicated the different phenotypes are underpinned by distinct mechanisms and have differential outcomes.

What is collectively needed, both companies maintain, are more efficient, safer, and scalable approaches to cell engineering.

AuraCyt measures cell physics to generate AI-ready digital fingerprints that reveal the multi-dimensional state and behavior of the cell.